Rraynex Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, sale, and research of healthcare products and medicines.
2021 | Mumbai, Maharashtra (India) | Active
Rraynex Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 1.59 M
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
- Revenue Growth %
- Profit Growth -28865.98%
- Ebitda -28860.60%
- Net Worth -78.70%
- Total Assets 77.60%
About Rraynex Pharmaceuticals
Rraynex Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2021 (Three years and three months 27 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 1.59 M.
The company currently has active open charges totaling ₹5.00 Cr.
Minal Desai, Raina Desai, and Nishit Gupta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299MH2021PTC371078
- Company No.
371078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Pharma
Who are the key members and board of directors at Rraynex Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishit Gupta  | Director | 09-Nov-2021 | Current |
| Minal Desai | Additional Director | 11-Aug-2023 | Current |
| Raina Desai | Director | 09-Nov-2021 | Current |
Financial Performance of Rraynex Pharmaceuticals.
Rraynex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28865.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 78.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rraynex Pharmaceuticals?
Unlock access to Rraynex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Desai Haribhakti Consulting Private LimitedMinal Desai is a mutual person
- Minal D. Desai Advisory Llp
Minal Desai is a mutual person
- Rynish Pharmaceuticals Private Limited
Minal Desai, Raina Desai and 1 more are mutual person
- Dhc Global Technologies Private Limited
Minal Desai and Raina Desai are mutual person
- Dbd Investments Limited
Minal Desai and Raina Desai are mutual person
- Dhc Global Centre Of Excellence Private Limited
Minal Desai is a mutual person
Charges (Loans)
Open Charges
₹5.00 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2024 | Axis Bank Limited | ₹5.00 Cr | Open |
How Many Employees Work at Rraynex Pharmaceuticals?
Rraynex Pharmaceuticals has a workforce of 0 employees as of Jun 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rraynex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rraynex Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rraynex Pharmaceuticals
Recent activity within the organization
- Charges
A charge with Axis Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101010006 was registered on 30 Oct 2024.
- Annual General Meeting
Rraynex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Rraynex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Minal Dilip Desai was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2023 & has been associated with this company since 1 year 6 months .
- Director Appointment
Raina Dilip Desai was appointed as a Director was appointed as a Director on 09 Nov 2021 & has been associated with this company since 3 years 3 months .
- Director Appointment
Nishit Gupta was appointed as a Director was appointed as a Director on 09 Nov 2021 & has been associated with this company since 3 years 3 months .
Frequently asked questions
What is the Incorporation or founding date of Rraynex Pharmaceuticals Private Limited?
Rraynex Pharmaceuticals Private Limited was incorporated on 09 Nov 2021.
What is authorized share capital and paid-up capital of Rraynex Pharmaceuticals Private Limited?
The authorized share capital of Rraynex Pharmaceuticals Private Limited is ₹ 15.00 Cr and paid-up capital is ₹ 1.59 M.
Who are the current board members & directors of Rraynex Pharmaceuticals Private Limited?
Currently 3 directors are associated with Rraynex Pharmaceuticals Private Limited.
- Minal Dilip Desai
- Raina Dilip Desai
- Nishit Gupta
What is the registered address of Rraynex Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rraynex Pharmaceuticals Private Limited is 701 7Th Floor Leela Business Park Opp Hotel Ak Road, Andheri(East) India, Mumbai, Maharashtra, 400059.
What is the corporate identification number (CIN) and company number of Rraynex Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Rraynex Pharmaceuticals Private Limited is U24299MH2021PTC371078 and the company number is 371078 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Rraynex Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Rraynex Pharmaceuticals Private Limited has experienced an downturn of -78.70%.
What are the total open charges for Rraynex Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Rraynex Pharmaceuticals Private Limited amount to ₹ 5.00 Cr.
When was the last Balance Sheet of Rraynex Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Rraynex Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.